Cargando…
Astragaloside IV alleviates heart failure via activating PPARα to switch glycolysis to fatty acid β-oxidation
In heart failure (HF), energy metabolism pathway in cardiac muscle changes from fatty acid β-oxidation to glycolysis. However, the exact mechanism is unknown. Sarcoendoplasmic reticulum Ca(2+)α ATPase (SERCA) expression is downregulated and mitochondrial function is reduced in HF, perhaps partly due...
Autores principales: | Dong, Zhiwei, Zhao, Pei, Xu, Ming, Zhang, Chen, Guo, Wei, Chen, Huihua, Tian, Jing, Wei, Hongchang, lu, Rong, Cao, Tongtong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457407/ https://www.ncbi.nlm.nih.gov/pubmed/28578382 http://dx.doi.org/10.1038/s41598-017-02360-5 |
Ejemplares similares
-
Astragaloside IV alleviates heart failure by modulating Nrf-2
por: Feng, Wenxiao, et al.
Publicado: (2022) -
Astragaloside IV alleviates heart failure by regulating SUMO-specific protease 1
por: Liu, Juan, et al.
Publicado: (2021) -
[Corrigendum] Astragaloside IV alleviates heart failure by regulating SUMO‑specific protease 1
por: Liu, Juan, et al.
Publicado: (2023) -
Astragaloside IV alleviates the symptoms of experimental ulcerative colitis in vitro and in vivo
por: Wu, Suxiao, et al.
Publicado: (2019) -
Effects of Astragaloside IV on heart failure in rats
por: Zhao, Zhuanyou, et al.
Publicado: (2009)